Company news

Vitasora Health Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cleansing Prospectus

October 19, 2020

Entech Electronics appointed as Global Manufacturing Partner

September 21, 2020

Positive wheezo clinical study results

August 31, 2020

Product Referral Agreement executed with Aust Patients Assoc

August 19, 2020

CY21 Revenue Guidance

July 26, 2020

Respiri signs with BNPL provider ZIP - update

July 20, 2020

Respiri signs with BNPL provider ZIP

July 19, 2020

Exclusive International Sales Agreement with Cipla

July 16, 2020

Agreement with UK Data Research Centre executed

June 25, 2020

Settlement with former CEO

June 18, 2020

Service Agreement with Pharmacy Guild of Australia

June 16, 2020

CEOs Address to Shareholders

May 26, 2020

Security Purchase Plan - Completed

May 5, 2020

Joint Development Agreement signed with Phenix Health

April 14, 2020

Placement completed

March 26, 2020

Placement - investor presentation

March 16, 2020

First batch of wheezos delivered

March 5, 2020

FDA update

January 30, 2020

FDA submission to be lodged

January 29, 2020

Cancellation of shares and options

December 19, 2019

SaaS model & First 500 devices

December 12, 2019

CE Mark, manufacturer & clinical study agreement

December 9, 2019

Chairmans Address to Shareholders

November 25, 2019

Director and CEO Appointment

November 24, 2019

Change of Chairman

November 14, 2019

Update regarding departure of CEO

October 29, 2019

CEO leaving

October 9, 2019

Medical trial in India update

September 20, 2019

Placement of ordinary shares

July 29, 2019

Suspension from Official Quotation

July 28, 2019

India Joint Venture Agreement

May 2, 2019

Appendix 4D and Interim Financial Report - December 2018

February 26, 2019

Completion Of Share Purchase Plan Offer

February 4, 2019

Respiris Share Purchase Plan

January 6, 2019

$3.2M Share Placement

December 18, 2018

Trading halt

December 13, 2018

Appendix 4C and R&D Incentive Announcement

October 29, 2018

Respiri appoints manufacturing partner

September 6, 2018

Appendix 4E and Audited FY2018 Financial Report

August 31, 2018

CEO Operational Review

July 30, 2018

Significant Milestone Progress

May 30, 2018

Respiri Limited - Functional Prototype Completed

April 19, 2018

Respiri limited $3.0m share placement

April 10, 2018

Appendix 4D and Interim Financial Report - December 2017

February 26, 2018

CEO Update and Reaffirmation of 2018 Plans and Milestones

January 29, 2018

Respiri Appoints New Chief Executive Officer

October 15, 2017

Response to ASX Price Query

October 10, 2017

Breath Sensor Partnership with Grey Innovation Commenced

September 12, 2017

Appendix 4E & Annual Financial Report (30 June 2017)

August 30, 2017

Commencing the last step to commercialisation

July 27, 2017

← Newer news releases · Older news releases →

Decks

The 5 newest of 15 decks. Every deck is listed under its year.